C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2006
11/23/2006	US20060264426 Antiinfective agent, antiproliferation agent, antiinflammatory agent or prokinetics
11/23/2006	US20060264425 Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
11/23/2006	US20060264415 Inhibitors of histone deacetylase
11/23/2006	US20060264385 like antiinfective (bactericide, fungicide, parasiticide, viricide), and antiproliferative, antiinflammatory, and prokinetic agents; 1,2,3-triazole-oxazolidine-phenyl- derivatives; effective against strains of cells or organisms that have developed drug resistance; administering orally
11/23/2006	DE102005044814A1 New spiro-isoxazole-cycloalkane compounds, useful as vanilloid receptor 1 ligands for treating e.g. pain, depression and neurodegeneration
11/23/2006	CA2609288A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
11/23/2006	CA2609002A1 Use of 2,5-disubstituted thiazol-4-one derivatives in the production of drugs for the treatment of disorders or diseases which are mediated at least partly by vanilloid receptors 1(vr1/trpv1 receptors)
11/23/2006	CA2608957A1 Pyrrolidine derivative or salt thereof
11/23/2006	CA2608599A1 Bicyclic derivatives as modulators of ion channels
11/23/2006	CA2608419A1 Substituted n-arylpyrrolidines as selective androgen receptor modulators
11/23/2006	CA2608014A1 Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
11/23/2006	CA2608012A1 Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
11/23/2006	CA2607422A1 4- (thiazol-2-ylthioalkyl) -pyrazoles and their use as herbicides
11/23/2006	CA2605050A1 Histone deacetylase inhibitors
11/22/2006	EP1724270A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/22/2006	EP1724268A1 Compound having tgf-beta inhibitory activity and pharmaceutical composition containing same
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724263A1 Basic amine compound and use thereof
11/22/2006	EP1724259A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indazol-5-yl)-octan amide derivatives and related compounds as renin inhibitors for the treatment of hypertension
11/22/2006	EP1724258A1 Heteroarylphenylurea derivative
11/22/2006	EP1723143A2 Amino cyclopropane carboxamide derivatives as bradykinin antagonists
11/22/2006	EP1723136A1 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
11/22/2006	EP1723132A1 Ep2 receptor agonists
11/22/2006	EP1723129A1 1-akan-2-ol substituted piperazine and piperidine compounds
11/22/2006	EP1723128A1 Heteroaryl-ureas and their use as glucokinase activators
11/22/2006	EP1723123A1 Ion channel modulators
11/22/2006	EP1723122A2 Dimeric small molecule potentiators of apoptosis
11/22/2006	EP1723121A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
11/22/2006	EP1723120A1 Ion channel modulators
11/22/2006	EP1723119A1 Ion channel modulators
11/22/2006	EP1723116A2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
11/22/2006	EP1722798A1 Pyrimidine compounds as purine receptor antagonist
11/22/2006	EP1722791A2 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
11/22/2006	EP1722788A2 Ion channel modulators
11/22/2006	EP1722787A1 Ion channel modulators
11/22/2006	EP1722785A1 Ion channel modulators
11/22/2006	EP1722784A2 Ion channel modulators
11/22/2006	EP1722783A2 Ion channel modulators
11/22/2006	EP1651644B1 Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same
11/22/2006	EP1501815B1 Substituted phenylacetamides and their use as glucokinase activators
11/22/2006	EP1501798A4 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS
11/22/2006	EP1438049B1 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
11/22/2006	EP1399156B1 Alkylidene pirazolidinedione derivatives and their use for treating diabetes and obesity
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1301487B1 Viral polymerase inhibitors
11/22/2006	EP1277752B1 Process for producing optically active sulfoxide derivative
11/22/2006	EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006	EP1238970B1 Cycloamine ccr5 receptor antagonists
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	CN1867567A 1-'(e)-2-(phenyl)ethenyl-4-(arylalkoxy)-oxazole or -thiazole compounds as her-2 tyrosine kinases inhibitors and their use in the treatment of cancer
11/22/2006	CN1867566A Aminopyrones and their use as ATM inhibitors
11/22/2006	CN1867565A Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1867552A Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change
11/22/2006	CN1867551A Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists
11/22/2006	CN1867547A Compounds having crth2 antagonist activity
11/22/2006	CN1867334A Quinolinone derivatives as inhibitors of c-fms kinase
11/22/2006	CN1865261A 2-substituted-benzothiazolyl-1,2,4-triazolinone derivative synthesis and herbicidal activity
11/22/2006	CN1865252A 4,5-di-substituted-phenyl-1,2,3-thiadia-zole derivative, and its preparation method and uses
11/22/2006	CN1865248A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
11/22/2006	CN1865219A 2- and 2,5-substituted phenylketo-enols
11/22/2006	CN1285588C Farnesyl protein transferase inhibitors
11/22/2006	CN1285580C Pyrimidine compounds
11/22/2006	CN1285572C Cannabinod receptor ligands
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006	US7138397 Nitrogenous 5-membered ring compounds
11/21/2006	US7138396 Treating androgen-dependent diseases, particularly benign prostatic hyperplasia, with a piperidinyl- or piperazinyl- N-(4-substituted pentamethylene)- or N-(4-substituted iminodiethylene)- acetamide derivative, optionally in combination with an alpha-1 adrenergic antagonist
11/21/2006	US7138361 Herbicidal heterocycles
11/21/2006	CA2199226C Process for the preparation of unsymmetrical 4,6-bis(aryloxy)pyrimidine compounds
11/21/2006	CA2187523C Pyranone compounds useful to treat retroviral infections
11/21/2006	CA2117413C Herbicidal isoxazole-4-yl-methanone derivatives
11/16/2006	WO2006122319A2 Histone deacetylase inhibitors
11/16/2006	WO2006122253A1 Process for making aztreonam
11/16/2006	WO2006122156A2 Compounds for modulating trpv3 function
11/16/2006	WO2006122014A2 Bicyclic derivatives as modulators of ion channels
11/16/2006	WO2006121218A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/16/2006	WO2006121106A1 Method for producing indole derivative having piperidine ring
11/16/2006	WO2006121097A1 Bicyclic heterocyclic derivative or salt thereof
11/16/2006	WO2006120478A2 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	WO2006120224A1 Fungicide 2-pyridyl-methylene-carboxamide derivatives
11/16/2006	WO2006088541A3 Quinoline derivatives and uses thereof
11/16/2006	WO2006076415A3 Exo- and diastereo- selective syntheses of himbacine analogs
11/16/2006	WO2005117882A3 Hydroxamic acid derivatives as metalloprotease inhibitors
11/16/2006	US20060258870 Process for producing bipyridinium compound
11/16/2006	US20060258861 Respiratory or gastrointestinal disorders; cancer
11/16/2006	US20060258860 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; for preventing, treating or delaying AIDS
11/16/2006	US20060258859 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/16/2006	US20060258725 4-(Substituted phenoxy or anilino)-3-phenyl- or phenylalkylisoxazoles: 3-{[(4-{[3-(2,6-Dichlorophenyl)-5-isopropylisoxazol-4-yl]methoxy}-2-methylphenyl)-(methyl)amino]methyl}benzoic acid; cardiovascular disease, cholestatic liver disease, organ fibrosis, triglycerides, increasing high density lipoprotein
11/16/2006	US20060258724 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents; Alzheimer's disease; anticancer agents
11/16/2006	US20060258721 neuronal nitric oxide synthase (nNOS) isoform inhibitors; 2-ethyl-1-(1H-indol-5-yl)-isothiourea; neurogenerative disorders, stroke, reperfusion injury, head trauma, migraine headache, neuropathic pain, drug abuse, hyperalgesia
11/16/2006	US20060258720 1-Aroyl-2-heteroaryl- or heterocyclyl-4-alkyl-4-pyrrolidinylcarboxylic acids or esters (rel-(2S,4R,5R)-2-Isobutyl-1-(3-methoxy-4-tert-butylbenzoyl)-4-ethoxymethyl-5-(1,3-thiazol-2-yl)pyrrolidine-2-carboxylic acid); antiviral agents; hepatitus C
11/16/2006	US20060258707 Benzimidazolidinone derivatives as muscarinic agents
11/16/2006	US20060258701 glucokinase-activating effect and is useful as a therapeutic agent for diabetes mellitus; 3-(4-methoxy-phenylsulfanyl)-6-(4H-[1,2,4]triazol-3-yl-sulfanyl)-N-([1,3,4]thiadiazol-2-yl)-2-pyridine carboxamide
11/16/2006	US20060258679 Process of preparing ziprasidone mesylate
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258657 Apoptosis promoters
11/16/2006	US20060258653 Derivatives of sulphonamides, their preparation and use as medicaments

1 ... 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 ... 628